Tivantinib
Tivantinib is the first non-ATP-competitive c-Met inhibitor with Ki of 0.355 μM in a cell-free assay, little activity to Ron, and no inhibition to EGFR, InsR, PDGFRα or FGFR1/4. Tivantinib (ARQ 197) induces a G2/M arrest and apoptosis.
Trivial name | ARQ 197 |
Catalog Number | S2753 |
Molecular Formula | C23H19N3O2 |
CAS# | 905854-02-6 |
Inchi | InChI=1S/C23H19N3O2/c27-22-19(16-11-24-18-9-2-1-7-14(16)18)20(23(28)25-22)17-12-26-10-4-6-13-5-3-8-15(17)21(13)26/h1-3,5,7-9,11-12,19-20,24H,4,6,10H2,(H,25,27,28)/t19-,20-/m0/s1 |
Inchi Key | UCEQXRCJXIVODC-PMACEKPBSA-N |
SMILES | C1CC2=C3C(=CC=C2)C(=CN3C1)C4C(C(=O)NC4=O)C5=CNC6=CC=CC=C65 |
Size | 50mg |
Supplier Page | http://www.selleckchem.com/products/arq-197.html |
Additional Information | https://file.selleck.cn/downloads/struct/ARQ-197-chemical-structure-s2753.gif |